Publications for Elisabeth Skogh

Publications for Elisabeth SkoghCo-author map based on ISI articles 2007-

Publications mentioned in social media 5 times*


taurine smoking smokers serum schizophrenia plasma patients olanzapine ola ng/ml kyna gsh fluid drug dmo csf controls cerebrospinal c/d acid

Journal Articles

Magdalena E. Kegel, Maria Bhat, Elisabeth Skogh, Martin Samuelsson, Kristina Lundberg, Marja-Liisa Dahl, Carl Sellgren, Lilly Schwieler, Göran Engberg, Ina Schuppe-Koistinen and Sophie Erhardt
  Imbalanced Kynurenine Pathway in Schizophrenia
  International Journal of Tryptophan Research, 2014, 7, 15-22.

Martin Samuelsson, Elisabeth Skogh, Kristina Lundberg, Magnus Vrethem and Karin Öllinger
  Taurine and glutathione in plasma and cerebrospinal fluid in olanzapine treated patients with schizophrenia
  Psychiatry Research, 2013, 210(3), 819-824.

Mao Mao, Elisabeth Skogh, Maria Gabriella Scordo and Marja-Liisa Dahl
  Letter: Interindividual Variation in Olanzapine Concentration Influenced by UGT1A4 L48V Polymorphism in Serum and Upstream FMO Polymorphisms in Cerebrospinal Fluid
Altmetric usage: 3

  Journal of Clinical Psychopharmacology, 2012, 32(2), 287-289.
 Web of Science® Times Cited: 3

Klas R Linderholm, Elisabeth Skogh, Sara K Olsson, Marja-Liisa Dahl, Maria Holtze, Göran Engberg, Martin Samuelsson and Sophie Erhardt
  Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
Altmetric usage: 1

  Schizophrenia Bulletin, 2012, 38(3), 426-432.
 Web of Science® Times Cited: 28

Elisabeth Skogh, Ingemar Sjödin, Martin Josefsson and Marja-Liisa Dahl
  High Correlation Between Serum and Cerebrospinal Fluid Olanzapine Concentrations in Patients With Schizophrenia or Schizoaffective Disorder Medicating With Oral Olanzapine as the Only Antipsychotic Drug
Altmetric usage: 1

  Journal of Clinical Psychopharmacology, 2011, 31(1), 4-9.
 Web of Science® Times Cited: 16

Elisabeth Skogh, Ingemar Sjödin, Martin Josefsson and M.L. Dahl
  Olanzapine in serum and cerebrospinal fluid in patients with schizophrenia or schizoaffective disorder
  European Neuropsychopharmacology, 2010, 20(Suppl. 3), S469-S469.

Martin Josefsson, Markus Roman, Elisabeth Skogh and Marja-Liisa Dahl
  Liquid chromatography/tandem mass spectrometry method for determination of olanzapine and N-desmethylolanzapine in human serum and cerebrospinal fluid
  Journal of Pharmaceutical and Biomedical Analysis, 2010, 53(3), 576-582.
 Web of Science® Times Cited: 14

Linda K Nilsson-Todd, Conny Nordin, Erik G Jönsson, Elisabeth Skogh and Sophie Erhardt
  Cerebrospinal fluid kynurenic acid in male patients with schizophrenia - Correlation with monoamine metabolites
  Acta Neuropsychiatrica, 2007, 19(1), 45-52.
 Web of Science® Times Cited: 3

Elisabeth Skogh, Margareta Reis, Marja-Liisa Dahl, Jöns Lundmark and Finn Bengtsson
  Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting
  Therapeutic Drug Monitoring, 2002, 24(4), 518-526.
 Web of Science® Times Cited: 59

Sophie Erhardt, Kaj Blennow, Conny Nordin, Elisabeth Skogh, Leif Lindström and Göran Engberg
  Kynurenic acid levels ae elevated in the cerebrospinal fluid of patients with schizophrenia
  Neuroscience Letters, 2001, 313(1-2), 96-98.
 Web of Science® Times Cited: 157

Elisabeth Skogh, Finn Bengtsson and Conny Nordin
  Could discontinuing smoking be hazardous for patients administered clozapine medication? A case report.
  Therapeutic Drug Monitoring, 1999, 21, 580-582.

Licentiate Theses

Elisabeth Skogh
  Studies on Variability in Olanzapine Disposition

  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by